Published in Blood Weekly, June 19th, 2008
In the first study, a randomized, multi-center U.S. study involving 48 centers, patients with SCLC and sensitive to previous first-line...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.